MedTrace Logo

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

NCT01301560 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2011-02-23

No results posted yet for this study

Summary

The need of radiosurgery is controversial for asymptomatic oligo brain metastasis for non small cell lung cancer (NSCLC).

Therefore, the investigators do a randomized study comparing overall survival between two groups with or without radiosurgery for asymptomatic oligo brain metastasis before palliative chemotherapy for NSCLC.

Conditions

  • Nonsmall Cell Lung Cancer

Interventions

RADIATION

Radiosurgery

Gamma knife surgery for asymptomatic oligo-metastasis to brain from NSCLC

RADIATION

Observation

No local treatment

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2013-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01301560 on ClinicalTrials.gov